Covid-19: Zwei Studien bestätigen das Fortbestehen einer anhaltenden kognitiven Beeinträchtigung bis zu einem Jahr nach der Infektion

1. Trender, William, et al. “Changes in memory and cognition during the SARS-CoV-2 human challenge study.” eClinicalMedicine, The Lancet, vol. 76, Oct. 2024, https://doi.org/10.1016/j.eclinm.2024.102842.
1. Wood, G. K., Sargent, B. F., Ahmad, Z., Tharmaratnam, K., Dunai, C., Egbe, F. N., Martin, N. H., Facer, B., Pendered, S. L., Rogers, H. C., Hübel, C., Van Wamelen, D. J., Bethlehem, R. a. I., Giunchiglia, V., Hellyer, P. J., Trender, W., Kalsi, G., Needham, E., Easton, A., Leek, E. C., et al., Sep. 2024, “Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.”, Nature Medicine. https://doi.org/10.1038/s41591-024-03309-8

En complément, ya une étude récente sur le mode d’action des symptômes qui persistent. Et un chemin vers un potentiel traitement pour les patients atteints de covid long.

Qui est déjà en essai clinique parce que c’est un traitement découvert dans le cadre d’autres maladie (Alzheimer, Sclérose en plaques).

> In a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks of the disease, while also suppressing the body’s ability to clear the virus. Importantly, the team also identified a new antibody therapy to combat all of these deleterious effects.

Le lien vers l’étude :

[Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy](https://gladstone.org/news/discovery-how-blood-clots-harm-brain-and-body-covid-19-points-new-therapy)

il était temps, j’ai enfin l’excuse pour être con !